Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:          
Net loss $ (2,797,971) $ (2,611,835) $ (1,876,491) $ (9,236,758) $ (4,502,877)
Adjustments to reconcile net loss to net cash used in operating activities          
Stock-based compensation 223,637   125,254 661,158 253,709
Changes in operating assets and liabilities:          
Prepaid expenses       763,159 967,106
Accounts payable       190,074 (26,771)
Accrued expenses       788,480 (129,085)
Net cash used in operating activities       (6,833,887) (3,437,918)
Cash flows from financing activities:          
Proceeds from issuance of common stock       6,646,748
Payment of offering costs   (248,927)   (248,927)
Proceeds from issuance of common stock upon exercise of options       52,400
Net cash provided by financing activities       6,450,221
Net decrease in cash       (383,666) (3,437,918)
Cash, beginning of period   $ 14,548,471   14,548,471 19,985,645
Cash, end of the period $ 14,164,805   $ 16,547,727 $ 14,164,805 $ 16,547,727